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Summary
INTRODUCTION
 Tuberculosis (TB) remains a major cause of morbidity and mortality worldwide. Triage 
is the initial stage that persons presumed to have TB will be directed to for proper disease 
management procedures.  Diagnosis of Pulmonary TB (PTB) in adults is usually done using 
clinical cardinal signs and symptoms followed by direct smear microscopy and sometimes with 
molecular techniques such GeneXpert where available.
  Although Lowenstein-Jensen (LJ) Culture is a gold standard for diagnostic of TB, it is not 
routinely performed.  There is limited information on the association between exposure factors 
and other clinical features apart from the cardinal signs with culture positivity.
 
OBJECTIVE 
 The aim of this study was to determine Socio-demographic  factors, Clinical features 
and Laboratory diagnostic results  associated with culture on confirmed diagnosis of Pulmonary 
Tuberculosis (PTB) .
METHODOLOGY 
 A total of 1869 participants presumed to have TB  in Health facilities were enrolled 
in the East Africa Public Health Laboratories Network  Project - Operational Research TB 
(EAPHLNP - OR TB) study.
 During the triage, clinical  history and physical examination was done. TB clinical 
symptoms  and signs  were recorded in a structured  medical form and that included the 
following:  productive cough, weight loss, night sweats, low grade fever (classical  cardinal  signs 
and symptoms),  general  patient condition, body temperature,  Body Mass Index (BMI), blood 
pressure, pulse,  respiratory rate, heart sounds (vital signs  and symptoms), pallor conjunctival 
presentation( aneamia ),  neck swellings(lymphadenopathy),  difficulty in breathing,  ease of air 
entry, percussion and auscultation findings(respiratory signs and symptoms ).  
 Sputum smear microscopy with  Ziehl-Neelsen (ZN) microscopy and Light Emitting Diodes 
(LEDs) for  Fluorescent Microscopy (FM) , GeneXpert and Culture.  Lowenstein-Jensen solid 
media was used as a gold standard for isolation of mycobacteria. Capilia Immuno-Chromagraphic 
Assay (ICA) was used to identify  Mycobacterium Tuberculosis  Complex(MTBC). Data was 
analysed with SPSS software and presented as frequency and percentages.  The Odd Ratio (OR) 
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and 95% Confidence Intervals (CI) was performed using a multivariate logistic regression model 
and Adjusted Odds Ratios (AOR) was performed for a final parsimonious multivariate logistic 
regression model . 
 Using a systematic backward approach, non-significant variables were removed from the 
model until no further variables were eligible for removal to arrive at the final parsimonious 
model. A p-value of <0.05 in the final model was considered statistically significant.
RESULTS
 Significant results from the final parsimonious multivariate logistic regression model 
included sociodemographic factors : Only one  study site AOR  =  3.91 (95%   CI = 1.76 - 8.71)
and   age group (20-29 years) Adjusted Odds Rates (AOR)  =  2.13  (95%   CI  = 1.10 - 4.10). 
Male gender showed marginal association 1.39  (95% CI =  0.96 - 2.01). Physical examination 
finding significant were weight loss AOR  = 1.94  ( 95% CI =  1.16-3.25),  Hepatomegaly 
AOR  =  0.22  (95%  CI =  0.05  -  0.92). Other cardinal signs and symptoms  of TB were not 
significantly associated.
CONCLUSION
 The clinical signs and symptoms   associated with TB in the parsimonious multivariate 
logistic regression model may be indicative of  health seeking behavior of participants  presumed 
to be having TB. However, these clinical findings provides an opportunity for consideration of 
which signs and symptoms to  be inclusive in improving early TB clinical diagnosis
[Afr. J. Health Sci. 2019 32(4) : 23 - 34]
Introduction 
 Tuberculosis (TB) remains a major cause 
of morbidity and mortality worldwide. Systematic 
screening for active TB is defined as the systematic 
identification of people with suspected active TB, in a 
predetermined target group, using tests, examinations 
or other procedures that can be applied rapidly [1]. 
 Options for the initial screening include 
Screening for symptoms (screening either for cough 
lasting for longer than 2 weeks), or Screening for any 
symptom compatible with TB, including cough of 
any duration, haemoptysis, weight loss, fever or night 
sweats.
 Diagnosis of pulmonary TB (PTB) in adults 
is usually done using clinical cardinal signs and 
symptoms followed by direct smear microscopy in (ZN 
and LED),  and sometimes with molecular techniques 
such GeneExpert where available [2,3,4]. 
 Globally the diagnosis of TB has been 
hampered by HIV pandemic [5,6] . HIV increases the 
rate of recurrent TB in this setting by increasing the rate 
of re-infection disease, not relapse [7]. 
 Culture is mostly performed at designated 
specific centres (WHO-algorithm for diagnosis of and 
drug susceptibility testing), but it has a long turn around 
time [1]. 
 TB was the leading cause of morbidity and 
mortality in Kenya [8].  Sputum culture and newer 
diagnostic techniques, although useful, were expensive 
and not widely available in resource-poor settings. 
 In Kenya, sputum culture is not usually 
performed for routine diagnosis due to several reasons. 
These include lack of adequate infrastructure focussing 
on safety issues, and skilled manpower in several health 
facilities.  
 Case detection in Kenya was mainly based on 
clinical triaging, microscopy and use of signs alone 
(which have high concordance).  There was a possibility 
for the use of  exposure factors, signs and symptoms, 
in settings with the absence or inadequate laboratory 
diagnostics. 
 There was likelly limited information on the 
association between exposure factors and other clinical 
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features apart from the cardinal signs with culture 
positivity.
 During the validation phase of the new 
TB diagnostics in the EAPHLNP, there arose an 
opportunity to perform culture on the specimens 
from people presumed to have TB who enrolled in the 
EAPHLNP project.
 The aim of this study was to determine Socio-
demographic factors, Clinical features and Laboratory 
diagnostic results  associated with culture-confirmed 
PTB .
Methodology
 In this cross-sectional study patients for 
intra-examiner and patients for  inter-examiner 
calibrations were  selected  from eligible respondents 
with symptoms or signs suggestive of TB. During 
the implementation of the East Africa Public Health 
laboratories Network Project  (EAPHLNP) in nine 
satelite sites  in Kenya. 
 TB clinical symptoms and signs recorded in a 
structured medical form include the following:
 Productive cough, Weight loss, Night sweats, 
Low grade fever(Classical  Cardinal  Signs and 
Symptoms), general patient condition, Body 
temperature, Body Mass Index( BMI), Blood 
Pressure, Pulse, Respiratory rate, Heart - Sounds 
(Vital Signs and Symptoms), Conjunctival 
presentation (Aneamia), Neck swellings 
(lymphadenopathy),  Difficulty in breathing,  Ease 
of air entry, Respiratory Signs and Symptoms) 
Percussion and auscultation findings.     
 These   were obtained by  the history of mor-
bidities and co-morbidities and physical examination of 
the enrolled  patients. 
 Using quality assurance sampling for a total 
population of ten thousand people with symptoms or 
signs suggestive of TB from the satellite sites. The 
minimum defective sample acceptable was 0 with a 
probability of defect accepted at 1% and an alpha of 
5% . The sample size of repeatable samples was 262 
patients in total for the satellite sites per year. 
 This gave a sampling interval of approximately 
50 patients per site per year. This translated to 1 
randomly selected patient per site per week. 
 Matching was done by the site clinical supervisor 
to ensure that every examiner was paired with another 
examiner so that the recommended number of matched 
results were obtained for each examiner.
 The results were in custody of the site clinical 
supervisor and released quarterly to the study team. The 
serial number of which patient to selected was computer 
generated. 
 These randomly selected recruited eligible 
patient suspects in the study  then underwent  intra-
examiner  (same clinician making two independent 
examinations on same patient  at recruitment and at 
delivery of morning sample ) and between clinicians 
or inter-examiner  (two clinicians  making two 
independent examinations on the same patient) the 
same day.  Calibration of the weight, height  and 
temperature tools for consistency were also done at the 
different sites.
 TB diagnosis was first  done by sputum smear 
microscopy Ziehl–Neelsen stain(ZN),  secondly by 
optimized sputum smear microscopy with a   Light 
Emitting Diodes microscope ( LED)  or fluorescent 
microscopy(FM), and thirdly  by  GeneXpert technique 
(GeneXpert or Gx). 
 The results from the clinicians and reference 
laboratory findings for these patients were entered 
in a computer, verified  and analyzed in SPSS  for 
reliability statistics of  the screening performance of all 
combinations and separate (Signs and Symptoms vs TB 
laboratory diagnosis) variables of interest. 
 These unweighted Cohen Kappa scores were 
interpreted as follows: 
 Poor   0.01 – 0.20
 Moderate  0.21 – 0.40
 Fair   0.41 – 0.60
 Good  0.61 – 0.80
 Excellent  0.81 – 1.0 
based on the agreement between the intra-examiner 
and inter-examiner findings in different TB laboratory 
diagnosis / HIV categories 
 Bivariate analysis was done to determine 
the association between culture positivity and socio-
demographic clinical features of patients and results of 
ZN, FM and GeneExpert. Multivariate binary logistic 
regression was also performed on these variables to 
determine the effects of covariate adjustment.















valuen % n %  L  U L U
Overall 265 15.7% 1424 84.3%
Study site
Busia 42 13.7% 265 86.3% 1.14 0.75 1.72 0.541 0.79 0.43 1.45 0.443
Kitale 73 19.4% 304 80.6% 1.72 1.20 2.47 0.003 1.51 0.76 3.01 0.239
Machakos 24 19.8% 97 80.2% 1.78 1.06 2.97 0.029 1.49 0.70 3.15 0.299
Kisii-Keroka 16 21.9% 57 78.1% 2.01 1.10 3.71 0.024 3.91 1.76 8.71 0.001
Nyahururu 17 20.5% 66 79.5% 1.85 1.02 3.34 0.041 2.14 0.95 4.83 0.067
Narok* 7 16.7% 35 83.3% 1.44 0.61 3.36 0.405 2.37 0.81 6.95 0.116
Lamu* 3 30.0% 7 70.0% 3.08 0.78 12.18 0.110 7.57 1.50 38.22 0.014
Wajir* 15 12.5% 105 87.5% 1.03 0.56 1.86 0.935 0.76 0.33 1.74 0.514
Malindi 68 12.2% 488 87.8% 1.00 1.00
Gender
Male 165 19.1% 701 80.9% 1.70 1.30 2.23 <0.001 1.39 0.96 2.01 0.078
Female 100 12.2% 723 87.8% 1.00 1.00
Age in years
<20 years 22 15.6% 119 84.4% 2.40 1.24 4.65 0.009 0.89 0.37 2.12 0.787
20 - 29 years 81 22.2% 284 77.8% 3.71 2.16 6.36 <0.001 2.13 1.10 4.10 0.024
30 - 39 years 76 19.2% 319 80.8% 3.10 1.80 5.32 <0.001 1.55 0.80 2.99 0.197
40 - 49 years 36 12.5% 251 87.5% 1.87 1.03 3.37 0.040 1.16 0.56 2.39 0.684
50 - 59 years 20 10.6% 168 89.4% 1.55 0.79 3.02 0.199 0.97 0.43 2.19 0.936
Missing 12 19.7% 49 80.3% 3.18 1.44 7.03 0.004 1.17 0.41 3.31 0.766
60 and above 
years
18 7.1% 234 92.9% 1.00 1.00
Results
 The extended Mantei-Haenszel chi-square 
for trend between sites was 5.83 (p =0.02) showing 
significant differences in occurrence of culture 
positivity. Significant results from the final 
parsimonious multivariate logistic regression model 
include  socio-demographic factors: Only one study 
site AOR  =  3.91 (95%    CI = 1.76 - 8.71) and age group 
(20 - 29 years)  AOR  =   2.13  (95%    CI  = 1.10 -  4.10). 
Male gender showed marginal association 1.39 (95% 
CI = 0.96 - 2.01). In a multivariate logistic regression 
parsimonious model indicated  that confounding, 
occurred at Kitale, Machakos and Nyahururu sites. 
 The odds ratios for Keroka and Nyahururu 
doubled after showing confounding adjustment for 
gender and all ages in the reproductive age except 20-25 
years was indicative of confounding. 
Table 1: Socio-Demographic Factors
* sample size inadequate OR : Odd Ratio                   CI : Confidence Interval            AOR  : Adjusted Ratio
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Figure 1: Distribution Of HIV Status, New and Retreated  TB Cases Among TB Culture Positive Individuals









Retreated 34 215 1
New 231 1191 1.23 0.83 1.81 0.302
Missing 0 18 ND ND ND 0.998
HIV status
Positive 61 293 1.18 0.85 1.65 0.316
Negative 135 768 1
Missing 69 363 1.081 0.789 1.483 0.627
Distribution of HIV status, new and 














Key:  95% CI:   Confidence Interval,  OR:   Odds Ratio,  L:  Lower limit,    U:   Upper limit
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 There was no significant difference between 
participants with TB retreated and newly TB diagnosed 
* Repeat red herring question for reliability of response
Figure 2: Distribution Of  Cardinal and Other Respiratory Signs and Symptoms 
 Distribution of  Cardinal and other Respiratory 
Signs and Symptoms 
*Blood stained sputum 1 16.6%








*Blood stained sputum 2 15.4%
Auscultation. Abnormal / added sounds 16.6%
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Proportion Percentage(%)
individuals with TB culture positivity. HIV status was 
not significantly associated with TB culture positivity.
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Table 3: Cardinal and Other Respiratory Signs and Symptoms.
Variables









L U L U
Duration of cough
<2 weeks 16 114 1.00
2- 4 weeks 99 504 1.40 0.80 2.47 0.244
>4 weeks 146 793 1.31 0.76 2.28 0.335
Missing 4 13 2.19 0.64 7.55 0.214
Productive cough
Yes 259 1392 0.99 0.41 2.40 0.986
No 6 32 1.00
Blood stained sputum
Yes 63 316 1.09 0.80 1.49 0.571
No 202 1108 1.00
Night sweats
Yes 228 1235 0.94 0.65 1.38 0.762
No 37 189 1.00
Fever
Yes 220 1144 1.20 0.85 1.69 0.309
No 45 280 1.00
Weight loss
Yes 229 1121 1.72 1.18 2.50 <0.001 1.94 1.16 3.25 0.012
No 36 303 1.00 1.00
Blood stained sputum
Yes 50 274 0.98 0.70 1.36 0.887
No 215 1150 1.00
Difficulty in breathing
Yes 102 496 1.17 0.89 1.53 0.253
No 163 928 1.00
Air entry
Reduced 112 553 1.15 0.88 1.50 0.294
Normal 153 871 1.00
Precussion note
Resonant 175 966 1.01 0.56 1.82 0.975
Dull 76 380 1.11 0.60 2.07 0.732
Normal 14 78 1.00
Auscultation
Abnormal / added sounds 101 508 1.11 0.85 1.46 0.448
Normal 164 916 1.00
Key:  95% CI: Confidence Interval,  OR: Odd Ratio,   AOR: Adjusted Ratio,  L: Lower limit,  U: Upper lim
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 Only weight loss showed significant association 
with culture positivity (OR =0 1.72(95% CI 1.18-2.50)p 

















that weight loss was an effect modifier. The odds ratios 
showed no statistical significant differences between 
the other signs and symptoms.
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(n=365)      
Negative 
(n=1424)
OR  95% CI               p value
n n L U
Conjuctiva
Pallor 44 222 1.08 0.76 1.54 0.677
Normal 221 1202 1.00
Neck pain
Yes 21 91 1.26 0.77 2.07 0.357
No 244 1333 1.00
Oedema
Present 11 64 0.92 0.48 1.77 0.803
Absent 254 1360 1.00
Epigastric pain
Yes 42 247 0.90 0.63 1.28 0.553
No 223 1177 1.00
Splenomegaly
Yes 14 113 0.65 0.37 1.15 0.133
No 251 1311 1.00
Hepatomegaly
Yes 2 47 0.22 0.05 0.92 0.023
No 263 1377 1.00
Hernia
Yes 4 18 1.20 0.40 3.57 0.746
No 261 1406 1.00
Any other masses
Yes 2 7 1.54 0.32 7.45 0.639
No 263 1417 1.00
Key:  95% CI: Confidence Interval,  OR: Odd Ratio,   AOR: Adjusted Ratio,  L: Lower limit,  U: Upper limit
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 Significant reduction of hepatomegaly was 
found in TB culture positive individuals (OR = 0.22 
(95% CI = 0.05 - 0.92)  p = 0.023). The odds ratios 
Figure 4: Distribution Of Microscopy and GeneXpert In Culture Positive Individuals At Study Sites.
showed no statistical significant differences between 
these signs and symptoms
Distribution Of  Microscopy And GeneXpert 
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Table 5: Microscopy and GeneXpert In Culture Positive Individuals at Study Sites
Variables





   OR      95% CI P value AOR  95% CI P value
L U L U
ZN site
Positive 178 77 36.57 25.69 52.04 <0.001 7.45 4.25 13.06 <0.001
Negative 77 1218 1.00 1.00
Missing 10 129 1.226 .619 2.429 0.559 0.78 0.36 1.71 0.537
FM site
Positive 143 72 39.12 26.34 58.10 <0.001 7.19 3.89 13.29 <0.001
Negative 53 1044 1.00 1.00
Missing 69 308 4.413 3.018 6.452 <0.001 1.82 1.04 3.17 0.036
GeneXpert site
Positive 70 42 32.35 18.21 57.45 <0.001 3.89 1.86 8.14 <0.00
 22 427 1.00 1.00
Missing 173 955 3.516 2.224 5.559 <0.001 1.13 0.59 2.18 0.716
Discussion
 The socio-demographic, clinical signs and 
symptoms   associated with  TB in the parsimonious 
multivariate logistic regression model included the 
Kisii-Keroka  site. Weight loss, lack of  hepatomegaly 
and TB diagnostics. These factors may be indicative of 
health seeking behaviour of participants presumed to 
have TB. 
 However, this clinical information provides 
consideration of which additional signs and symptoms 
to   include improving early TB clinical diagnosis. 
The sample size was in Lamu was small, limiting 
interpretation of the significant association with TB 
culture positivity.  
 The extent to which the signs and symptoms 
are associated with culture positivity show the extent 
to which damage has occurred to the various parts of 
the body. Systemic examination for the different signs 
and symptom revealed, lack of association with culture 
positivity except with weight los.  lack of hepatomegaly. 
The speed of progression to clinically detectable disease 
depends largely on the immune competency of the host. 
 
 Apparently, there was lack of association 
between  HIV and Culture Positivity in this study . This 
was also observed in a study in Luska , Zambia where 
there was a strong trend towards lower grade or negative 
sputum smear in the HIV-positive group (P = 0.003)[9]. 
HIV-positive cases also had lower colony counts on 
Culture and colonies took longer to appear.
 The primary objective of screening for active 
TB was to ensure that, active TB was detected early 
and treatment initiated promptly. The ultimate aim is 
reducing the risk of poor treatment outcome, health 
sequelae, adverse social and economic consequences of 
TB in helping to reduce TB transmission globally. 
Negative
Key:  95% CI: Confidence Interval,  OR: Odd Ratio,   AOR: Adjusted Ratio,  L: Lower limit,  U: Upper limit
34 African Journal of Health Sciences, Volume 32, Issue No. 4, July - August, 2019
 For TB control, the highest priority was to 
detect at least 70% of the sputum smear positive cases 
and to cure at least 85% of the sputum smear positive 
cases. If these targets are achieved, there will be a 
decrease in prevalence incidences of transmission and 
drug resistance to TB [10,11].   
 Microscopy was significantly associated with 
culture positivity focusing on the likelihood of success 
of screening in resource constrained settings. 
 In a case control study in Southern Ethiopia 
smear-positive pulmonary TB was associated with HIV 
infections, previous episodes of TB, low body-mass 
index, drinking unpasteurized milk and sharing a 
bedroom with more than three individuals. 
 Even though not significant after controlling 
the effect of confounders; being male gender, illiteracy, 
low monthly income, being farmer and bad housing 
condition were associated with active pulmonary TB in 
univariate analysis [12]
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